<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clinicopathologic records and neuropathologic tissues of 109 patients who underwent necropsy after treatment with bone marrow transplantation (BMT) were examined </plain></SENT>
<SENT sid="1" pm="."><plain>Underlying disorders included <z:hpo ids='HP_0001909'>leukemia</z:hpo> (70), <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (25), <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> (7), <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (5), <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (1) and <z:e sem="disease" ids="C0043194" disease_type="Disease or Syndrome" abbrv="">Wiskott-Aldrich syndrome</z:e> (1) </plain></SENT>
<SENT sid="2" pm="."><plain>There were 34 females and 75 males, ranging in age from 2 to 56 years </plain></SENT>
<SENT sid="3" pm="."><plain>Survival after transplantation averaged 3.6 months </plain></SENT>
<SENT sid="4" pm="."><plain>The most common findings were cerebrovascular lesions (29), including <z:mp ids='MP_0008817'>hematomas</z:mp>, hemorrhagic <z:mp ids='MP_0001651'>necrosis</z:mp>, and <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> comprised the next most common finding, including 10 fungal and four <z:mp ids='MP_0001794'>bacterial</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>A recurrence of underlying <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> for which transplant had been performed occurred in five patients </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0002352'>Leukoencephalopathy</z:hpo> of varying severity was found in eight patients, half of whom had received intrathecal chemotherapy and/or cranial radiation </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with systemic <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> had a variety of nonspecific neuropathologic findings in the <z:mp ids='MP_0008912'>nervous</z:mp> system; however, nearly half (44%) showed no detectable changes </plain></SENT>
<SENT sid="9" pm="."><plain>Other nonspecific alterations included hypoxic/ischemic changes, vascular siderocalcinosis, and neuroaxonal spheroids (associated with <z:mp ids='MP_0001914'>hemorrhage</z:mp> or <z:mp ids='MP_0001651'>necrosis</z:mp>) </plain></SENT>
<SENT sid="10" pm="."><plain>These findings provide a guide as to likely causes of a neurologic syndrome in a patient who has undergone BMT, and can be compared with neuropathologic findings in other forms of immunosuppression </plain></SENT>
</text></document>